Efficacy Study of a New Eyedrop on Silicone Hydrogel Contact Lens Wearers With Dry Eye Complaints
NCT ID: NCT01543061
Last Updated: 2013-09-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
35 participants
INTERVENTIONAL
2012-02-29
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
New study eye drop
One month of contact lens wear with use of the Test study eye drops
OPTIVEtm Plus
1 drop in each eye four times a day for a period of 30 (± 3) days
No Eyedrop
One month of contact lens wear with no eye drop use
No treatment
One month of contact lens wear with no eye drop use
BLINK Contacts Lubricating eye drop
One month of contact lens wear with use of the Control study eye drops
Blink Contacts® Eye Drops
1 drop in each eye four times a day for a period of 30 (± 3) days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OPTIVEtm Plus
1 drop in each eye four times a day for a period of 30 (± 3) days
No treatment
One month of contact lens wear with no eye drop use
Blink Contacts® Eye Drops
1 drop in each eye four times a day for a period of 30 (± 3) days
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Complaints of contact lens related dry eye (Symptoms and reduced comfortable wearing time)
Exclusion Criteria
* Systemic or ocular allergies
* Use of systemic medication which might have ocular side effects.
* Any ocular infection.
* Use of ocular medication.
* Significant ocular tissue anomaly
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Allergan
INDUSTRY
Optometric Technology Group Ltd
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michel Guillon, PhD
Role: PRINCIPAL_INVESTIGATOR
Optometric Technology Group Ltd
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
OTG Research & Consultancy
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AG9965-006 ID 11-19
Identifier Type: -
Identifier Source: org_study_id